Success Metrics

Clinical Success Rate
73.7%

Based on 14 completed trials

Completion Rate
74%(14/19)
Active Trials
0(0%)
Results Posted
93%(13 trials)
Terminated
5(26%)

Phase Distribution

Ph phase_3
5
26%
Ph phase_4
1
5%
Ph phase_1
2
11%
Ph phase_2
11
58%

Phase Distribution

2

Early Stage

11

Mid Stage

6

Late Stage

Phase Distribution19 total trials
Phase 1Safety & dosage
2(10.5%)
Phase 2Efficacy & side effects
11(57.9%)
Phase 3Large-scale testing
5(26.3%)
Phase 4Post-market surveillance
1(5.3%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

73.7%

14 of 19 finished

Non-Completion Rate

26.3%

5 ended early

Currently Active

0

trials recruiting

Total Trials

19

all time

Status Distribution
Completed(14)
Terminated(5)

Detailed Status

Completed14
Terminated5

Development Timeline

Analytics

Development Status

Total Trials
19
Active
0
Success Rate
73.7%
Most Advanced
Phase 4

Trials by Phase

Phase 12 (10.5%)
Phase 211 (57.9%)
Phase 35 (26.3%)
Phase 41 (5.3%)

Trials by Status

completed1474%
terminated526%

Recent Activity

0 active trials
Showing 5 of 19
completedphase_2

Efficacy and Safety of Peginesatide (AF37702) in the Treatment of Anemia in Participants With Chronic Kidney Disease

NCT00314795
completedphase_3

Conversion Study From Epoetin Alfa to Monthly Peginesatide Injection in Patients With Chronic Kidney Disease on Dialysis

NCT01478971
terminatedphase_4

Evaluation of the Conversion From Peginesatide to Epoetin Alfa in Patients Receiving Hemodialysis

NCT01737879
completedphase_3

Safety & Efficacy of Peginesatide for Maintenance Treatment of Anemia in Participants With Chronic Kidney Disease on Hemodialysis

NCT00597584
completedphase_3

Safety & Efficacy of Peginesatide for Maintenance Treatment of Anemia in Participants With Chronic Kidney Disease on Hemodialysis

NCT00597753
View all 19 trials

Clinical Trials (19)

Showing 19 of 19 trials
NCT00314795Phase 2

Efficacy and Safety of Peginesatide (AF37702) in the Treatment of Anemia in Participants With Chronic Kidney Disease

Completed
NCT01478971Phase 3

Conversion Study From Epoetin Alfa to Monthly Peginesatide Injection in Patients With Chronic Kidney Disease on Dialysis

Completed
NCT01737879Phase 4

Evaluation of the Conversion From Peginesatide to Epoetin Alfa in Patients Receiving Hemodialysis

Terminated
NCT00597584Phase 3

Safety & Efficacy of Peginesatide for Maintenance Treatment of Anemia in Participants With Chronic Kidney Disease on Hemodialysis

Completed
NCT00597753Phase 3

Safety & Efficacy of Peginesatide for Maintenance Treatment of Anemia in Participants With Chronic Kidney Disease on Hemodialysis

Completed
NCT00598273Phase 3

Safety & Efficacy of Peginesatide for the Treatment of Anemia in Participants With Chronic Renal Failure Not on Dialysis

Completed
NCT00598442Phase 3

Safety and Efficacy of Peginesatide for the Treatment of Anemia in Participants With Chronic Renal Failure Not on Dialysis

Completed
NCT00228436Phase 2

Safety, PD & PK of Multiple Doses of Peginesatide for Anemia in Chronic Kidney Disease Patients

Completed
NCT00272662Phase 2

Study of Subcutaneously Administered Peginesatide in Anemic Cancer Patients Receiving Chemotherapy

Completed
NCT00109291Phase 2

Safety of Single Doses of Peginesatide in Patients With Chronic Kidney Disease

Terminated
NCT00097747Phase 1

Safety and Pharmacokinetics of Single Intravenous Doses of Peginesatide in Healthy Volunteers

Completed
NCT00228449Phase 2

Peginesatide for Anemia in Chronic Hemodialysis Patients

Completed
NCT00752791Phase 2

Efficacy and Safety of Peginesatide Injection for the Maintenance Treatment of Anemia in Peritoneal Dialysis Participants Previously Treated With Epoetin.

Completed
NCT00752609Phase 2

Safety and Efficacy of Peginesatide Injection for the Maintenance of Anemia in Chronic Renal Failure Participants Who Are on Hemodialysis or Do Not Require Dialysis and Previously Treated With Darbepoetin Alfa.

Completed
NCT00434330Phase 2

Peginesatide for Maintenance Treatment of Anemia in Participants on Hemodialysis

Completed
NCT00372489Phase 2

Extension Study to Evaluate Safety and Tolerability of Peginesatide for Long-Term Treatment of Anemia in Participants With CKD

Terminated
NCT00453973Phase 2

Extension Study to Evaluate Safety and Tolerability of Peginesatide for Long-Term Treatment of Anemia in Participants With CKD (EU)

Terminated
NCT00680043Phase 2

Safety & Efficacy of Peginesatide for Treatment of Anemia in Participants on Dialysis Not Receiving an ESA

Completed
NCT00629876Phase 1

A Safety and Tolerability Study of Peginesatide in Anemic Cancer Patients Receiving Cytotoxic Chemotherapy.

Terminated

All 19 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
19